European tech weekly recap: More than 65 tech funding deals worth over €1.8B
European tech weekly recap: More than 65 tech funding deals worth over €1.8B

Last week, we tracked more than 65 tech funding deals worth over €1.8 billion and over 5 exits, M&A transactions, rumours, and related news stories across Europe.📊 The top three industries that ra…

Germany’s New Robot Billionaire Is Betting Big On Humanoid Gyms

David Reger’s $7 billion Neura Robotics wants to be the Apple of physical AI, building not only an army of industrial and humanoid robots, but also their operating software system and the “gyms” where they will train. Nvidia, Amazon and Tether are onb…

This Startup Wants To Catch AI’s Mistakes

A flight recorder for wayward AI systems. The space industry’s record investments. AI spending warnings. All that and more in this week’s Prototype.

Why Debt-Laden Neoclouds Could Become A Trillion Dollar WeWork 2.0

Data center developers and neoclouds raised $37 billion in U.S. junk bonds this year. As yields hit double digits, debt tied to riskier AI firms is tumbling.

Healthcare Has Always Failed Women. These Founders Are Fixing It

The most urgent gaps in women’s health aren’t waiting for a breakthrough. Meet two of the founders Serena Williams is mentoring through Reckitt Catalyst.

You Can Now Preserve Your Immune Cells For $5,000 In Case They’re Helpful In The Future

Your immune cells are constantly aging. Cellino is launching a new service, called Reservoir, to let people securely store them from a simple blood draw for $5,000.

GLP-1s Took Eli Lilly To $1 Trillion. CEO Dave Ricks Is Betting Billions He Can Do It Again

CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs. But with more than 60% of revenue coming from them, the drug giant faces the risks of its own success.

Unprecedented Cyberattack Used Malware Ads To Spy On Journalists, Report Says

A new report from Citizen Lab researchers shows how spyware companies can hack anyone viewing an online advertisement.

Two Dozen-Plus Biotechs Went Public This Year—With More In The Works

In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.

Know Your Airline Passenger Rights As U.S. And EU Rules Diverge

New U.S. and EU air passenger rules are diverging. Here’s how delayed and canceled flight rights differ—and why your airline and departure airport matter.